Loading…

Effect of CD40 ligand on the course of murine histoplasmosis

CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histopla...

Full description

Saved in:
Bibliographic Details
Published in:Medical Mycology 2002, Vol.40 (5), p.501-505
Main Authors: Wheat, L. J., Durkin, M., Schnizlein-Bick, C., Bassey, E., Kohler, S., Connolly, P., Goldberg, J., Garringer, T., Brizendine, E., Thomas, E. K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713
cites cdi_FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713
container_end_page 505
container_issue 5
container_start_page 501
container_title Medical Mycology
container_volume 40
creator Wheat, L. J.
Durkin, M.
Schnizlein-Bick, C.
Bassey, E.
Kohler, S.
Connolly, P.
Goldberg, J.
Garringer, T.
Brizendine, E.
Thomas, E. K.
description CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histoplasma capsulatum yeast and monitored for clearance of the organism from the lungs and spleen. CD40L treatment was begun on either day-2 or +2 post inoculation and continued until day 14 in CD4-depleted animals and from day-2 to day +4 in nonimmunosuppressed animals. Amphotericin B treatment was begun four days following inoculation and given every other day for 10 days. CD40L reduced fungal burden by less than one log when started two days before infection but did not act synergistically with low-dosage amphotericin B (0.2 mg kg-1 qod) in CD4 depleted mice. Low-dose amphotericin B, CD40L, and the combination of the two failed to lower the fungal burden in a second experiment using a more virulent isolate of the same strain of H. capsulatum in CD4-depleted mice. Furthermore, CD40L did not increase the concentrations of IFN-γ, IL-12 or IL-10 in the lungs or spleens of infected animals. In summary, CD40L had minimal or no effect on the course of infection in this murine model of histoplasmosis.
doi_str_mv 10.1080/mmy.40.5.501.505
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72726061</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1080/mmy.40.5.501.505</oup_id><sourcerecordid>72726061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713</originalsourceid><addsrcrecordid>eNqNkD1PwzAQhi0EoqWwM6EssKCUsy-OG8SCSvmQKrHAbDmuTVMlcbGTof8el1bqhMRwsqV73rPvIeSSwpjCBO6aZjPOYMzHHGgsfkSGFHOWIhT8-PdepCgm-YCchbACoKJgeEoGlGU54whD8jCz1ugucTaZPmWQ1NWXaheJa5NuaRLteh_Mttn0vmpNsqxC59a1Co0LVTgnJ1bVwVzszxH5fJ59TF_T-fvL2_Rxnur4AZ6iLkWBVpWmEGyCqLlFQSkuyqwsWZlxS1EhlhmywgLNOWiOjFqkmhVcUByRm93ctXffvQmdbKqgTV2r1rg-SMEEyyHfgrADtXcheGPl2leN8htJQW6NyWhMZiC5jMZi8Ri52s_uy8YsDoG9oghc7wEVtKqtV62uwoHLAEQRtxqR2x3n-vV_nr3f0VVrnW_U0qi6W2rljVxF6W3U-Xf4Bzh6kvo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72726061</pqid></control><display><type>article</type><title>Effect of CD40 ligand on the course of murine histoplasmosis</title><source>Oxford Journals Online</source><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Wheat, L. J. ; Durkin, M. ; Schnizlein-Bick, C. ; Bassey, E. ; Kohler, S. ; Connolly, P. ; Goldberg, J. ; Garringer, T. ; Brizendine, E. ; Thomas, E. K.</creator><creatorcontrib>Wheat, L. J. ; Durkin, M. ; Schnizlein-Bick, C. ; Bassey, E. ; Kohler, S. ; Connolly, P. ; Goldberg, J. ; Garringer, T. ; Brizendine, E. ; Thomas, E. K.</creatorcontrib><description>CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histoplasma capsulatum yeast and monitored for clearance of the organism from the lungs and spleen. CD40L treatment was begun on either day-2 or +2 post inoculation and continued until day 14 in CD4-depleted animals and from day-2 to day +4 in nonimmunosuppressed animals. Amphotericin B treatment was begun four days following inoculation and given every other day for 10 days. CD40L reduced fungal burden by less than one log when started two days before infection but did not act synergistically with low-dosage amphotericin B (0.2 mg kg-1 qod) in CD4 depleted mice. Low-dose amphotericin B, CD40L, and the combination of the two failed to lower the fungal burden in a second experiment using a more virulent isolate of the same strain of H. capsulatum in CD4-depleted mice. Furthermore, CD40L did not increase the concentrations of IFN-γ, IL-12 or IL-10 in the lungs or spleens of infected animals. In summary, CD40L had minimal or no effect on the course of infection in this murine model of histoplasmosis.</description><identifier>ISSN: 1369-3786</identifier><identifier>EISSN: 1362-3095</identifier><identifier>EISSN: 1460-2709</identifier><identifier>DOI: 10.1080/mmy.40.5.501.505</identifier><identifier>PMID: 12462530</identifier><language>eng</language><publisher>UK: Informa UK Ltd</publisher><subject>Animals ; Bacterial diseases ; Biological and medical sciences ; CD4 Antigens - physiology ; CD40 Ligand - physiology ; CD40 Ligand - therapeutic use ; Experimental bacterial diseases and models ; Fundamental and applied biological sciences. Psychology ; Histoplasmosis - drug therapy ; Histoplasmosis - immunology ; Infectious diseases ; Interferon-gamma ; Interleukin-10 - analysis ; Interleukin-12 - analysis ; Lung - immunology ; Medical sciences ; Mice ; Microbiology ; Mycology ; Pathogenicity, host-agent relations, miscellaneous strains, epidemiology</subject><ispartof>Medical Mycology, 2002, Vol.40 (5), p.501-505</ispartof><rights>2002 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2002</rights><rights>2002 ISHAM 2002</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713</citedby><cites>FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4021,27921,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14007983$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12462530$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wheat, L. J.</creatorcontrib><creatorcontrib>Durkin, M.</creatorcontrib><creatorcontrib>Schnizlein-Bick, C.</creatorcontrib><creatorcontrib>Bassey, E.</creatorcontrib><creatorcontrib>Kohler, S.</creatorcontrib><creatorcontrib>Connolly, P.</creatorcontrib><creatorcontrib>Goldberg, J.</creatorcontrib><creatorcontrib>Garringer, T.</creatorcontrib><creatorcontrib>Brizendine, E.</creatorcontrib><creatorcontrib>Thomas, E. K.</creatorcontrib><title>Effect of CD40 ligand on the course of murine histoplasmosis</title><title>Medical Mycology</title><addtitle>Med Mycol</addtitle><description>CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histoplasma capsulatum yeast and monitored for clearance of the organism from the lungs and spleen. CD40L treatment was begun on either day-2 or +2 post inoculation and continued until day 14 in CD4-depleted animals and from day-2 to day +4 in nonimmunosuppressed animals. Amphotericin B treatment was begun four days following inoculation and given every other day for 10 days. CD40L reduced fungal burden by less than one log when started two days before infection but did not act synergistically with low-dosage amphotericin B (0.2 mg kg-1 qod) in CD4 depleted mice. Low-dose amphotericin B, CD40L, and the combination of the two failed to lower the fungal burden in a second experiment using a more virulent isolate of the same strain of H. capsulatum in CD4-depleted mice. Furthermore, CD40L did not increase the concentrations of IFN-γ, IL-12 or IL-10 in the lungs or spleens of infected animals. In summary, CD40L had minimal or no effect on the course of infection in this murine model of histoplasmosis.</description><subject>Animals</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>CD4 Antigens - physiology</subject><subject>CD40 Ligand - physiology</subject><subject>CD40 Ligand - therapeutic use</subject><subject>Experimental bacterial diseases and models</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Histoplasmosis - drug therapy</subject><subject>Histoplasmosis - immunology</subject><subject>Infectious diseases</subject><subject>Interferon-gamma</subject><subject>Interleukin-10 - analysis</subject><subject>Interleukin-12 - analysis</subject><subject>Lung - immunology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Microbiology</subject><subject>Mycology</subject><subject>Pathogenicity, host-agent relations, miscellaneous strains, epidemiology</subject><issn>1369-3786</issn><issn>1362-3095</issn><issn>1460-2709</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqNkD1PwzAQhi0EoqWwM6EssKCUsy-OG8SCSvmQKrHAbDmuTVMlcbGTof8el1bqhMRwsqV73rPvIeSSwpjCBO6aZjPOYMzHHGgsfkSGFHOWIhT8-PdepCgm-YCchbACoKJgeEoGlGU54whD8jCz1ugucTaZPmWQ1NWXaheJa5NuaRLteh_Mttn0vmpNsqxC59a1Co0LVTgnJ1bVwVzszxH5fJ59TF_T-fvL2_Rxnur4AZ6iLkWBVpWmEGyCqLlFQSkuyqwsWZlxS1EhlhmywgLNOWiOjFqkmhVcUByRm93ctXffvQmdbKqgTV2r1rg-SMEEyyHfgrADtXcheGPl2leN8htJQW6NyWhMZiC5jMZi8Ri52s_uy8YsDoG9oghc7wEVtKqtV62uwoHLAEQRtxqR2x3n-vV_nr3f0VVrnW_U0qi6W2rljVxF6W3U-Xf4Bzh6kvo</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Wheat, L. J.</creator><creator>Durkin, M.</creator><creator>Schnizlein-Bick, C.</creator><creator>Bassey, E.</creator><creator>Kohler, S.</creator><creator>Connolly, P.</creator><creator>Goldberg, J.</creator><creator>Garringer, T.</creator><creator>Brizendine, E.</creator><creator>Thomas, E. K.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Effect of CD40 ligand on the course of murine histoplasmosis</title><author>Wheat, L. J. ; Durkin, M. ; Schnizlein-Bick, C. ; Bassey, E. ; Kohler, S. ; Connolly, P. ; Goldberg, J. ; Garringer, T. ; Brizendine, E. ; Thomas, E. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>CD4 Antigens - physiology</topic><topic>CD40 Ligand - physiology</topic><topic>CD40 Ligand - therapeutic use</topic><topic>Experimental bacterial diseases and models</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Histoplasmosis - drug therapy</topic><topic>Histoplasmosis - immunology</topic><topic>Infectious diseases</topic><topic>Interferon-gamma</topic><topic>Interleukin-10 - analysis</topic><topic>Interleukin-12 - analysis</topic><topic>Lung - immunology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Microbiology</topic><topic>Mycology</topic><topic>Pathogenicity, host-agent relations, miscellaneous strains, epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wheat, L. J.</creatorcontrib><creatorcontrib>Durkin, M.</creatorcontrib><creatorcontrib>Schnizlein-Bick, C.</creatorcontrib><creatorcontrib>Bassey, E.</creatorcontrib><creatorcontrib>Kohler, S.</creatorcontrib><creatorcontrib>Connolly, P.</creatorcontrib><creatorcontrib>Goldberg, J.</creatorcontrib><creatorcontrib>Garringer, T.</creatorcontrib><creatorcontrib>Brizendine, E.</creatorcontrib><creatorcontrib>Thomas, E. K.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical Mycology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wheat, L. J.</au><au>Durkin, M.</au><au>Schnizlein-Bick, C.</au><au>Bassey, E.</au><au>Kohler, S.</au><au>Connolly, P.</au><au>Goldberg, J.</au><au>Garringer, T.</au><au>Brizendine, E.</au><au>Thomas, E. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of CD40 ligand on the course of murine histoplasmosis</atitle><jtitle>Medical Mycology</jtitle><addtitle>Med Mycol</addtitle><date>2002</date><risdate>2002</risdate><volume>40</volume><issue>5</issue><spage>501</spage><epage>505</epage><pages>501-505</pages><issn>1369-3786</issn><eissn>1362-3095</eissn><eissn>1460-2709</eissn><abstract>CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histoplasma capsulatum yeast and monitored for clearance of the organism from the lungs and spleen. CD40L treatment was begun on either day-2 or +2 post inoculation and continued until day 14 in CD4-depleted animals and from day-2 to day +4 in nonimmunosuppressed animals. Amphotericin B treatment was begun four days following inoculation and given every other day for 10 days. CD40L reduced fungal burden by less than one log when started two days before infection but did not act synergistically with low-dosage amphotericin B (0.2 mg kg-1 qod) in CD4 depleted mice. Low-dose amphotericin B, CD40L, and the combination of the two failed to lower the fungal burden in a second experiment using a more virulent isolate of the same strain of H. capsulatum in CD4-depleted mice. Furthermore, CD40L did not increase the concentrations of IFN-γ, IL-12 or IL-10 in the lungs or spleens of infected animals. In summary, CD40L had minimal or no effect on the course of infection in this murine model of histoplasmosis.</abstract><cop>UK</cop><pub>Informa UK Ltd</pub><pmid>12462530</pmid><doi>10.1080/mmy.40.5.501.505</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1369-3786
ispartof Medical Mycology, 2002, Vol.40 (5), p.501-505
issn 1369-3786
1362-3095
1460-2709
language eng
recordid cdi_proquest_miscellaneous_72726061
source Oxford Journals Online; Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Animals
Bacterial diseases
Biological and medical sciences
CD4 Antigens - physiology
CD40 Ligand - physiology
CD40 Ligand - therapeutic use
Experimental bacterial diseases and models
Fundamental and applied biological sciences. Psychology
Histoplasmosis - drug therapy
Histoplasmosis - immunology
Infectious diseases
Interferon-gamma
Interleukin-10 - analysis
Interleukin-12 - analysis
Lung - immunology
Medical sciences
Mice
Microbiology
Mycology
Pathogenicity, host-agent relations, miscellaneous strains, epidemiology
title Effect of CD40 ligand on the course of murine histoplasmosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T22%3A01%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20CD40%20ligand%20on%20the%20course%20of%20murine%20histoplasmosis&rft.jtitle=Medical%20Mycology&rft.au=Wheat,%20L.%20J.&rft.date=2002&rft.volume=40&rft.issue=5&rft.spage=501&rft.epage=505&rft.pages=501-505&rft.issn=1369-3786&rft.eissn=1362-3095&rft_id=info:doi/10.1080/mmy.40.5.501.505&rft_dat=%3Cproquest_cross%3E72726061%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72726061&rft_id=info:pmid/12462530&rft_oup_id=10.1080/mmy.40.5.501.505&rfr_iscdi=true